Valneva SE

VALN · NYSE

$5.26−$0.10 (−1.87%)TodayMarket closed · Oct 23, 7:55 PM ET

Prev close $5.36

Latest news

Press releaseOct 14, 11:45 AM ETGlobe Newswire
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
NewsOct 14, 6:05 AM ET
Full Transcript: Valneva Q2 2026 Earnings Call
NewsOct 8, 2:27 PM ETVandana Singh
UK Revokes Approval for Valneva's Chikungunya Shot
Press releaseOct 7, 4:00 PM ETGlobe Newswire
Valneva Provides Update on IXCHIQ® in the United Kingdom
NewsAug 25, 7:39 AM ETAvi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
NewsAug 24, 8:04 AM ETAvi Kapoor
Applied Optoelectronics, SanDisk, Seagate And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
NewsAug 14, 12:46 PM ETVandana Singh
European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application
NewsAug 14, 12:02 PM ETAvi Kapoor
Dow Falls Over 100 Points; US Consumer Sentiment Declines In August
NewsAug 14, 8:06 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseAug 14, 1:00 AM ETGlobe Newswire
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
Press releaseAug 14, 1:00 AM ETBusiness Wire
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
NewsAug 13, 1:11 AM ET
Valneva Reports H1 2026 Product Sales Of €64.0M Down From €91.0M YoY, Net Loss Widens To €63.3M From €20.8M YoY
Press releaseAug 13, 1:00 AM ETGlobe Newswire
Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates
NewsAug 11, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseJul 22, 11:45 AM ETGlobe Newswire
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
NewsMay 13, 11:51 AM ET
Transcript: Valneva Q1 2026 Earnings Conference Call
NewsMay 13, 7:11 AM ET
Earnings Scheduled For May 13, 2026
Press releaseMay 13, 1:00 AM ETGlobe Newswire
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates
NewsMay 11, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsMay 4, 8:02 AM ETAvi Kapoor
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Press releaseApr 30, 10:40 PM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
Press releaseApr 28, 6:26 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
NewsApr 22, 8:02 AM ETAvi Kapoor
Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
NewsApr 22, 5:31 AM ETAvi Kapoor
Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Press releaseApr 21, 5:21 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
Press releaseApr 16, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
Press releaseApr 14, 5:11 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
Press releaseApr 9, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
Press releaseMar 31, 6:06 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
Press releaseMar 26, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
Press releaseMar 24, 5:49 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN
NewsMar 24, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsMar 23, 3:15 PM ETAvi Kapoor
Crude Oil Falls Sharply; Dell Shares Spike Higher
NewsMar 23, 10:35 AM ETVandana Singh
Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive
NewsMar 23, 10:22 AM ETAvi Kapoor
Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February
Press releaseMar 23, 6:45 AM ETBusiness Wire
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
Press releaseMar 18, 8:00 AM ETPRNewswire
Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program
NewsJan 20, 3:58 PM ETVandana Singh
Valneva Steps Back From US Approval Bid For Chikungunya Vaccine
NewsJan 6, 10:07 AM ETAvi Kapoor
Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday
NewsNov 26, 12:30 PM ETVandana Singh
Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings
Press releaseOct 18, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
NewsAug 25, 3:02 PM ETAvi Kapoor
Crude Oil Surges 2%; Chicago Fed National Activity Index Edges Lower in July
NewsJul 23, 11:00 AM ETAvi Kapoor
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Full Transcript: Valneva Q2 2026 Earnings Call

UK Revokes Approval for Valneva's Chikungunya Shot

Valneva Provides Update on IXCHIQ® in the United Kingdom

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Applied Optoelectronics, SanDisk, Seagate And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application

Dow Falls Over 100 Points; US Consumer Sentiment Declines In August

12 Health Care Stocks Moving In Friday's Pre-Market Session

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Valneva Reports H1 2026 Product Sales Of €64.0M Down From €91.0M YoY, Net Loss Widens To €63.3M From €20.8M YoY

Valneva Reports Half Year 2026 Financial Results and Provides Corporate Updates

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026

Transcript: Valneva Q1 2026 Earnings Conference Call

Earnings Scheduled For May 13, 2026

Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates

12 Health Care Stocks Moving In Monday's Pre-Market Session

Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Crude Oil Falls Sharply; Dell Shares Spike Higher

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Dow Jumps Over 800 Points; Chicago Fed National Activity Index Declines In February

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program

Valneva Steps Back From US Approval Bid For Chikungunya Vaccine

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN

Crude Oil Surges 2%; Chicago Fed National Activity Index Edges Lower in July

GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday